|
|
xxiii | |
In Memoriam |
|
xxix | |
Preface to the Fourth Edition |
|
xxxi | |
Abbreviations |
|
xxxiii | |
Relevant Lab Values in Adults and Children |
|
xxxvii | |
|
|
|
I HISTORY, CHEMISTRY METABOLISM, CIRCULATION & REGULATION |
|
|
|
1 Historical Overview of Vitamin D |
|
|
|
|
Discovery of the Vitamins |
|
|
3 | (2) |
|
Discovery of the Physiological Functions of Vitamin D |
|
|
5 | (1) |
|
Discovery of the Hormonal Form of Vitamin D |
|
|
6 | (3) |
|
|
9 | (1) |
|
|
9 | (5) |
|
2 Evolutionary Biology: Mysteries of Vitamin D in Fish |
|
|
|
|
Biological Distribution of Vitamin D |
|
|
14 | (1) |
|
Evolutionary Origins of Vitamin D |
|
|
14 | (2) |
|
Evolution of Vitamin D Function |
|
|
16 | (1) |
|
Origin of Vitamin D in Fish |
|
|
16 | (3) |
|
Functional Metabolism of Vitamin D in Fish |
|
|
19 | (1) |
|
A Possible Role for Sunlight in the Origin of Vitamin D in Fish |
|
|
19 | (2) |
|
Vitamin D Function in Fish |
|
|
21 | (2) |
|
Transport of Vitamin D and Its Metabolites |
|
|
23 | (1) |
|
Vitamin D Toxicity From Oral Ingestion |
|
|
23 | (1) |
|
|
24 | (6) |
|
3 Evolution of Human Skin Color and Vitamin D |
|
|
|
|
|
30 | (1) |
|
The Solar Context of Human Skin Color Evolution |
|
|
30 | (1) |
|
The Nature of the Selective Factors Leading to the Evolution of Skin Pigmentation in Early Homo |
|
|
31 | (1) |
|
Folate Conservation and the Evolution of Permanent Protective Pigmentation |
|
|
32 | (1) |
|
Early Hominin Dispersal Out of the Tropics and Vitamin D Production |
|
|
32 | (4) |
|
The Evolution of Skin Pigmentation in Homo sapiens |
|
|
36 | (2) |
|
The Effects of Cultural Buffering, Rapid Migrations, and Modern Lifestyles on Skin Color and Vitamin D |
|
|
38 | (2) |
|
|
40 | (4) |
|
|
44 | (1) |
|
4 Photobiology of Vitamin D |
|
|
|
|
|
45 | (1) |
|
|
45 | (1) |
|
Photobiology of Vitamin D |
|
|
46 | (4) |
|
Role of Sunlight and Dietary Vitamin D in Bone Health, Overall Health, and Well-being |
|
|
50 | (1) |
|
Sunlight, Vitamin D, and Skin Cancer |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
53 | (2) |
|
|
55 | (2) |
|
5 The Activating Enzymes of Vitamin D Metabolism (25- and 1α-Hydroxylases) |
|
|
|
|
|
|
|
57 | (2) |
|
General Information Regarding Vitamin D Hydroxylases |
|
|
59 | (1) |
|
Vitamin D3-25-Hydroxylases |
|
|
59 | (7) |
|
25-Hydroxyvitamin D-1α-hydroxylase |
|
|
66 | (4) |
|
|
70 | (4) |
|
|
74 | (7) |
|
6 CYP24A1: Structure, Function, and Physiological Role |
|
|
|
|
|
|
81 | (1) |
|
CYP24A1-Catalyzed Pathways |
|
|
82 | (1) |
|
|
82 | (1) |
|
C23-Hydroxylation Pathway |
|
|
83 | (1) |
|
CYP24A1, a Multifunctional Enzyme |
|
|
83 | (1) |
|
Biological Relevance of the C24-Oxidation Pathway |
|
|
84 | (1) |
|
Structure-Function Relationships |
|
|
84 | (1) |
|
Mutations of CYP24A1 and Idiopathic Infantile Hypercalcemia |
|
|
85 | (2) |
|
Preclinical Models of Idiopathic Infantile Hypercalcemia |
|
|
87 | (1) |
|
Putative CYP24A1 Involvement in Other Systems |
|
|
87 | (1) |
|
CYP24A1 in Chronic Kidney Disease |
|
|
87 | (1) |
|
Role of 24,25(OH)2D in Chondrocyte Maturation |
|
|
88 | (1) |
|
24,25(OH)2D and Fracture Repair |
|
|
88 | (2) |
|
|
90 | (1) |
|
|
91 | (6) |
|
7 The Vitamin D-Binding Protein |
|
|
|
|
|
|
97 | (1) |
|
|
98 | (1) |
|
Vitamin D-Binding Protein: Gene and Protein Structure |
|
|
99 | (3) |
|
Functions of Vitamin D-Binding Protein |
|
|
102 | (5) |
|
The Vitamin D-Binding Protein-Actin Complex |
|
|
107 | (2) |
|
Conclusions and Perspectives |
|
|
109 | (1) |
|
|
110 | (7) |
|
8 Regulation of Renal and Extrarenal 1α-Hydroxylase |
|
|
|
|
|
|
|
117 | (1) |
|
|
118 | (3) |
|
Extrarenal Expression of 1α-Hydroxylase |
|
|
121 | (8) |
|
Conclusions and Future Prospects |
|
|
129 | (1) |
|
|
130 | (12) |
|
|
|
9 Genome-Wide Perspectives on Vitamin D Receptor--Mediated Control of Gene Expression in Target Cells |
|
|
|
|
|
|
|
|
|
142 | (1) |
|
|
142 | (2) |
|
The Metabolic Activation of Vitamin D |
|
|
144 | (2) |
|
Overview of the Vitamin D Receptor: The Protein, Its Structure, and Function |
|
|
146 | (3) |
|
Recent Advances in the Mechanisms of Action of Vitamin D |
|
|
149 | (10) |
|
Advances in Understanding the Regulation of the Vitamin D Receptor Gene |
|
|
159 | (4) |
|
Exploiting Humanized VDR Transgenic Mice to Understand Expression, Regulation, and VDR Protein Function In Vivo |
|
|
163 | (2) |
|
Establishing a Humanized Mouse Model for the Study of Human Disease |
|
|
165 | (2) |
|
|
167 | (1) |
|
|
167 | (1) |
|
|
167 | (8) |
|
10 Diverse Mechanisms of Transcriptional Regulation by the Vitamin D Receptor |
|
|
|
|
|
|
|
|
175 | (1) |
|
Interplay Between Transforming Growth Factor β and Vitamin D Receptor Signaling |
|
|
176 | (1) |
|
The Vitamin D Receptor and Transcription Factor Activator Protein-1 |
|
|
177 | (1) |
|
Interplay Between VDR and JAK/STAT Signaling in Immunity |
|
|
177 | (1) |
|
Regulation of Wnt Signaling by the Vitamin D Receptor: A Molecular Basis for Cancer Prevention |
|
|
177 | (2) |
|
Control of FoxO Protein Function by the Vitamin D Receptor |
|
|
179 | (1) |
|
Regulation of the c-MYC/MXD1 Network by the Hormone-Bound Vitamin D Receptor |
|
|
180 | (2) |
|
Multiple Mechanisms of Regulation of NF-κ B Signaling by the Hormone-Bound Vitamin D Receptor |
|
|
182 | (1) |
|
Insights Into Transcriptional Regulation by the Vitamin D Receptor from Genomics Studies |
|
|
183 | (1) |
|
|
183 | (1) |
|
|
183 | (6) |
|
11 Structural Basis for Ligand Activity in Vitamin D Receptor |
|
|
|
|
|
|
189 | (2) |
|
1α, 25-Dihydroxyvitamin D3 Recognition by Vitamin D Receptor |
|
|
191 | (2) |
|
|
193 | (1) |
|
Other Vitamin D Receptor Natural Ligands |
|
|
194 | (1) |
|
Secosteroidal Analogs of 1α, 25-Dihydroxyvitamin D3 |
|
|
195 | (5) |
|
Structures of Vitamin D Receptor With Analogs That Induce Structural Rearrangements |
|
|
200 | (3) |
|
Synthetic Mimics of 1α,25-Dihydroxyvitamin D3 |
|
|
203 | (2) |
|
Conclusions and Perspectives |
|
|
205 | (1) |
|
|
205 | (1) |
|
|
206 | (5) |
|
12 Ligand-Independent Actions of Vitamin D Receptor |
|
|
|
|
|
|
211 | (1) |
|
Skeletal Defects Induced by Impaired Vitamin D Receptor Signaling |
|
|
211 | (1) |
|
Ligand-Independent Role of Vitamin D Receptor in Hair Cycle |
|
|
212 | (1) |
|
Unliganded Vitamin D Receptor Repressive Activities Induce Severe Skeletal Defects |
|
|
212 | (1) |
|
Toward Improved Diagnosis and Treatments of Hereditary Vitamin D Resistant Rickets Patients |
|
|
213 | (1) |
|
Conclusion and Perspectives |
|
|
214 | (1) |
|
|
215 | (1) |
|
|
215 | (2) |
|
13 Vitamin D and Chromatin |
|
|
|
|
|
217 | (1) |
|
The Nuclear Receptor Superfamily Member Vitamin D Receptor |
|
|
218 | (1) |
|
Genome-Wide Location of Vitamin D Receptor-Binding Sites |
|
|
219 | (1) |
|
CTCF as Organizer of Vitamin D-Dependent Chromatin Domains |
|
|
220 | (1) |
|
The Impact of Epigenomics |
|
|
220 | (1) |
|
Vitamin D-Triggered Epigenome Changes |
|
|
221 | (1) |
|
A Chromatin Model of Vitamin D Signaling Emerges |
|
|
222 | (1) |
|
Vitamin D Signaling In Vivo |
|
|
222 | (1) |
|
|
223 | (1) |
|
|
224 | (1) |
|
|
224 | (3) |
|
14 Mesenchymal Differentiation, Epigenetic Dynamics, and Interactions With VDR |
|
|
|
|
|
|
Genetic Control of Mesenchymal Lineage Cells |
|
|
227 | (4) |
|
Epigenetic Fate Determination |
|
|
231 | (3) |
|
Osteoblast Enhancer Complex: Consolidated and Dispersed |
|
|
234 | (4) |
|
Dynamics of Transdifferentiation |
|
|
238 | (2) |
|
|
240 | (1) |
|
|
240 | (1) |
|
|
240 | (5) |
|
15 Vitamin D and MicroRNAs |
|
|
|
|
|
|
|
|
245 | (2) |
|
MicroRNAs: The Posttranscriptional Age |
|
|
247 | (1) |
|
Complexity of MicroRNA Regulation, Biogenesis, and Posttranscriptional Regulatory Actions |
|
|
247 | (3) |
|
Nuclear Receptors and MicroRNAs |
|
|
250 | (1) |
|
Duality Among MicroRNAs and the Vitamin D Synthesis, Metabolism, and Signaling Systems |
|
|
250 | (5) |
|
Interplay Between Vitamin D and MicroRNAs in Biological Systems |
|
|
255 | (5) |
|
Strategies for MicroRNA and Target Identification for Vitamin D Research |
|
|
260 | (1) |
|
|
261 | (1) |
|
|
262 | (1) |
|
|
262 | (7) |
|
16 Vitamin D Sterol/Vitamin D Receptor Conformational Dynamics and Nongenomic Actions |
|
|
|
|
|
|
269 | (1) |
|
1α, 25(OH)2 Vitamin D3 Regulation of Genomic Versus Nongenomic Signaling |
|
|
270 | (1) |
|
Vitamin D3 Sterol Chemistry |
|
|
271 | (4) |
|
1,25(OH)2D3-Mediated Rapid, Nongenomic Responses |
|
|
275 | (5) |
|
The Plasma Membrane Vitamin D Receptor |
|
|
280 | (1) |
|
The Vitamin D Receptor Conformational Ensemble Model |
|
|
281 | (5) |
|
Vitamin D Receptor Ligand Specificity: Does an Unliganded Vitamin D Receptor Ever Exist In Vivo? |
|
|
286 | (1) |
|
|
287 | (8) |
|
III MINERAL AND BONE HOMEOSTASIS |
|
|
|
17 Vitamin D Regulation of Osteoblast Function |
|
|
|
|
|
|
|
|
295 | (1) |
|
Properties of Mature Osteoblasts and Osteocytes |
|
|
295 | (2) |
|
Major Regulatory Functions of Osteoblasts and Osteocytes and Control by the Vitamin D Endocrine System |
|
|
297 | (3) |
|
Effects of 1,25(OH)2D3 on Osteoblast Differentiation |
|
|
300 | (2) |
|
Regulation of Intracellular Signaling Pathways by 1,25(OH)2D3 |
|
|
302 | (1) |
|
|
303 | (1) |
|
|
304 | (5) |
|
18 Osteoclastogenesis and Vitamin D |
|
|
|
|
|
|
|
|
309 | (1) |
|
Regulation of Mineral Metabolism by Vitamin D, Parathyroid Hormone, and Fibroblast Growth Factor 23 |
|
|
310 | (1) |
|
Phenotypes of Vitamin D Receptor Knockout Mice |
|
|
311 | (1) |
|
Regulation of Osteoclastogenesis by the Receptor Activator of Nuclear Factor-κ B Ligand/Receptor Activator of Nuclear Factor-κ B/Osteoprotegerin System |
|
|
312 | (1) |
|
In Vitro Regulation of Osteoclastogenesis by Vitamin D |
|
|
312 | (1) |
|
In Vivo Regulation of Osteoclastogenesis by Vitamin D Compounds |
|
|
313 | (2) |
|
|
315 | (1) |
|
|
316 | (3) |
|
19 Vitamin D Activities in Osteocytes |
|
|
|
|
|
|
|
|
319 | (1) |
|
Cell Biology of Osteocytes |
|
|
320 | (1) |
|
Direct Actions of 1,25-Dihydroxyvitamin D on Osteocyte Maturation and Activities |
|
|
321 | (1) |
|
Receptor Activator of Nuclear Factor κ B Ligand |
|
|
321 | (2) |
|
Vitamin D Metabolism Within Osteocytes |
|
|
323 | (1) |
|
The Role of Osteocytes and Vitamin D in Bone Turnover |
|
|
323 | (1) |
|
The Role of Vitamin D and Osteocytes in Endocrine Feedback |
|
|
324 | (1) |
|
|
324 | (1) |
|
|
325 | (4) |
|
20 Regulation of Intestinal Calcium and Phosphate Absorption |
|
|
|
|
An Overview of Intestinal Calcium Absorption |
|
|
329 | (7) |
|
An Overview of Intestinal Phosphate Absorption |
|
|
336 | (2) |
|
|
338 | (5) |
|
21 Calbindin-D28K and Calbindin-D9K and the Epithelial Calcium Channels TRPV5 and TRPV6 |
|
|
|
|
|
|
Introduction and General Considerations, the Calbindins |
|
|
343 | (2) |
|
Localization and Proposed Functional Significance of the Calbindins |
|
|
345 | (4) |
|
Regulation of Calbindin Gene Expression |
|
|
349 | (2) |
|
Epithelial Calcium Channels |
|
|
351 | (2) |
|
|
353 | (1) |
|
|
354 | (7) |
|
22 Calcium Homeostasis and Eggshell Biomineralization in Female Chicken |
|
|
|
|
|
|
361 | (1) |
|
Mineralization Associated With Laying Hen Reproduction |
|
|
362 | (2) |
|
Transepithelial Transfer of Calcium |
|
|
364 | (5) |
|
Regulation of Calcium Metabolism in Hens |
|
|
369 | (9) |
|
|
378 | (1) |
|
|
378 | (5) |
|
23 Mineralization in Mammals |
|
|
|
|
|
383 | (1) |
|
Direct and Indirect Effects of Vitamin D and Vitamin D Metabolites on Mineralization |
|
|
384 | (3) |
|
Methods for Quantifying Tissue Mineralization |
|
|
387 | (4) |
|
Mechanism of Effects of Vitamin D on Mineralization |
|
|
391 | (3) |
|
Mineralization and Mineral Properties in Systems With Vitamin D Alterations |
|
|
394 | (3) |
|
|
397 | (1) |
|
|
398 | (1) |
|
|
398 | (5) |
|
|
403 | (2) |
|
|
|
|
|
|
|
Properties of Cartilage Tissues |
|
|
405 | (1) |
|
|
406 | (4) |
|
Rapid Actions of Vitamin D and Nongenomic Mechanisms |
|
|
410 | (4) |
|
|
414 | (1) |
|
|
414 | (5) |
|
25 Vitamin D and Bone: An Integrated Approach |
|
|
|
|
Link Between Bone Metabolism, Calcium Homeostasis, and 1,25(OH)2D3 Activity |
|
|
419 | (1) |
|
1,25(OH)2D3 and Bone Metabolism During a Positive Calcium Balance |
|
|
420 | (4) |
|
Negative Calcium Balance Resulting From Insufficient Vitamin D Action |
|
|
424 | (2) |
|
Negative Calcium Balance With Sufficient Vitamin D |
|
|
426 | (2) |
|
Vitamin D and Fibroblast Growth Factor 23 |
|
|
428 | (1) |
|
|
429 | (1) |
|
|
430 | (7) |
|
IV EXTRA-SKELETAL TARGETS |
|
|
|
26 Vitamin D and the Kidney |
|
|
|
|
|
|
437 | (2) |
|
Role of the Kidney in the Metabolism of 25-Hydroxyvitamin D |
|
|
439 | (2) |
|
Effects of Vitamin D, 25(OH)D3 and 1α, 25(OH)2D3 on the Renal Handling of Calcium and Phosphorus |
|
|
441 | (1) |
|
Distribution and Regulation of Vitamin D-Dependent Proteins in the Kidney |
|
|
442 | (8) |
|
|
450 | (1) |
|
|
450 | (11) |
|
27 Vitamin D and the Parathyroids |
|
|
|
|
|
|
461 | (1) |
|
Parathyroid Hormone Biosynthesis |
|
|
462 | (1) |
|
The Parathyroid Hormone Gene |
|
|
462 | (1) |
|
Development of the Parathyroid and Tissue-Specific Expression of the Parathyroid Hormone Gene |
|
|
463 | (1) |
|
Regulation of Parathyroid Hormone Gene Expression |
|
|
463 | (7) |
|
|
470 | (1) |
|
|
471 | (6) |
|
28 The Calcium-Sensing Receptor and Vitamin D |
|
|
|
|
|
477 | (1) |
|
The Calcium-Sensing Receptor |
|
|
478 | (3) |
|
Overview of Extracellular Ca2+ Homeostasis: Roles of Calcium-Sensing Receptor and Vitamin D Receptor |
|
|
481 | (1) |
|
Calcium-Sensing Receptor and Vitamin D Receptor in Tissues Involved in Ca2+ Homeostasis |
|
|
482 | (7) |
|
Calcium-Sensing Receptor and Vitamin D Receptor in Tissues Uninvolved in Extracellular Ca2+ Homeostasis |
|
|
489 | (1) |
|
Mouse Models of Calcium-Sensing Receptor Deletion Relative to Presentation in Humans |
|
|
490 | (1) |
|
|
490 | (1) |
|
|
490 | (7) |
|
29 Vitamin D in Dentoalveolar and Oral Health |
|
|
|
|
|
|
497 | (1) |
|
A Brief Primer on Dentoalveolar Cells and Tissues |
|
|
498 | (3) |
|
Vitamin D Metabolism and Mechanisms of Action on Dental Cells |
|
|
501 | (2) |
|
Vitamin D, Rickets, and the Oral Tissues |
|
|
503 | (3) |
|
Hereditary Vitamin D-Related Diseases and Dentoalveolar Tissues |
|
|
506 | (5) |
|
Vitamin D and Oral Health |
|
|
511 | (2) |
|
|
513 | (1) |
|
|
513 | (1) |
|
|
513 | (8) |
|
30 The Role of Vitamin D and Its Receptor in Hair Follicle Biology |
|
|
|
|
|
521 | (1) |
|
|
521 | (2) |
|
|
523 | (1) |
|
Pathways Important for Keratinocyte Stem Cell Function |
|
|
523 | (1) |
|
The Vitamin D Receptor Suppresses PPARγ Signaling in Keratinocyte Stem Cells |
|
|
524 | (1) |
|
|
524 | (1) |
|
|
525 | (2) |
|
31 Vitamin D, Calcium, and the Epidermis |
|
|
|
|
|
527 | (1) |
|
Cutaneous Production of Vitamin D and Its Biologically Active Metabolites |
|
|
528 | (1) |
|
Regulation of Keratinocyte Differentiation |
|
|
529 | (8) |
|
Role of Vitamin D Signaling in Skin Cancer |
|
|
537 | (1) |
|
Role of Vitamin D Signaling in Epidermal Wound Repair |
|
|
538 | (1) |
|
|
539 | (6) |
|
32 Vitamin D and the Cardiovascular System |
|
|
|
|
|
|
|
545 | (1) |
|
|
546 | (1) |
|
Identification of the Vitamin D Receptor in the Vascular System |
|
|
546 | (1) |
|
|
547 | (1) |
|
Structural Vascular Changes |
|
|
548 | (1) |
|
|
549 | (2) |
|
|
551 | (1) |
|
Blood Coagulation and Fibrinolysis |
|
|
552 | (1) |
|
|
552 | (3) |
|
Clinical Studies in Cardiovascular Disease |
|
|
555 | (1) |
|
|
556 | (1) |
|
|
556 | (1) |
|
|
557 | (7) |
|
33 Vitamin D Brain Development and Function |
|
|
|
|
|
|
564 | (1) |
|
Vitamin D Signaling in the Brain |
|
|
564 | (3) |
|
Dietary Vitamin D Deficiency, Effect on Brain Development and Function |
|
|
567 | (4) |
|
The Effects of Excess Vitamin D on Brain Development and Function |
|
|
571 | (1) |
|
Vitamin D Regulates Essential Processes in Normal Brain Development |
|
|
572 | (1) |
|
Possible Neuroprotective Mechanisms of Vitamin D in the Developing Brain |
|
|
573 | (1) |
|
Developmental Vitamin D Deficiency and Neuropsychiatric Disorders |
|
|
574 | (1) |
|
|
575 | (1) |
|
|
576 | (7) |
|
34 Vitamin D, Vitamin D Receptor, and Adipose Tissue: Focus on Cellular Mechanisms |
|
|
|
|
|
|
Adipose Tissue: Storage Depot and Target for Vitamin D |
|
|
583 | (2) |
|
Effect of Vitamin D on Adipogenesis at the Cellular Level |
|
|
585 | (5) |
|
Impact of Vitamin D Signaling on Adiposity in Mouse Models |
|
|
590 | (2) |
|
Translational Considerations |
|
|
592 | (1) |
|
Conclusions and Future Directions |
|
|
593 | (1) |
|
|
593 | (4) |
|
35 Vitamin D and Skeletal Muscle |
|
|
|
|
Skeletal Muscle Physiology |
|
|
597 | (1) |
|
Vitamin D Receptor in Muscle |
|
|
598 | (3) |
|
Vitamin D and Calcium Signaling in Muscle |
|
|
601 | (1) |
|
Vitamin D and Phosphate Signaling in Muscle |
|
|
602 | (1) |
|
Vitamin D and Insulin Signaling in Muscle |
|
|
602 | (1) |
|
Vitamin D, Muscle Contraction, and Strength |
|
|
603 | (1) |
|
Vitamin D, Muscle Development, and Mass |
|
|
604 | (2) |
|
Vitamin D, Muscle Injury, and Repair |
|
|
606 | (1) |
|
Vitamin D and Age-Related Changes in Muscle |
|
|
606 | (1) |
|
Vitamin D and Bone Muscle Cross-Talk |
|
|
607 | (1) |
|
Conclusions and Future Directions |
|
|
607 | (2) |
|
|
609 | (5) |
|
36 Understanding Vitamin D From Mouse Knockout Models |
|
|
|
|
|
|
|
|
|
614 | (1) |
|
1,25 Dihydroxyvitamin D/Vitamin D Receptor System and Mineral and Skeletal Homeostasis |
|
|
614 | (5) |
|
Extraskeletal Actions of 1,25 dihydroxyvitamin D |
|
|
619 | (6) |
|
|
625 | (1) |
|
|
625 | (6) |
|
|
631 | (5) |
|
|
|
37 Pharmacology and Pharmacokinetics |
|
|
|
|
|
|
636 | (1) |
|
|
636 | (2) |
|
Kinetics of Cutaneous Synthesis |
|
|
638 | (1) |
|
|
639 | (2) |
|
Metabolism and Determinants of Metabolic Fate of Vitamin D |
|
|
641 | (1) |
|
Half-Lives of Vitamin D Metabolites |
|
|
642 | (2) |
|
Factors Influencing Vitamin D Half-Life |
|
|
644 | (2) |
|
The Pharmacokinetics of Bound and Free Vitamin D Metabolites |
|
|
646 | (1) |
|
Influence of Vitamin D-Binding Protein Genotype and Concentration on Vitamin D Metabolism and 25(OH)D Half-Life |
|
|
647 | (1) |
|
Dose-Response to Vitamin D Supplementation |
|
|
648 | (4) |
|
The 3-Epimer of 25(OH)D and 1,25(OH)2D |
|
|
652 | (1) |
|
|
652 | (1) |
|
|
653 | (1) |
|
|
653 | (1) |
|
|
653 | (10) |
|
38 Vitamin D Role in the Calcium and Phosphorus Economies |
|
|
|
|
|
|
663 | (1) |
|
Overview of the Calcium Economy |
|
|
663 | (5) |
|
Overview of the Phosphorus Economy |
|
|
668 | (1) |
|
Calcium and Phosphorus Absorptive Inputs |
|
|
669 | (5) |
|
Physiological Sources of Vitamin D Activity |
|
|
674 | (1) |
|
|
675 | (1) |
|
|
676 | (1) |
|
|
676 | (3) |
|
39 Fetus, Neonate, and Infant |
|
|
|
|
Overview of Calcium Metabolism in the Fetus |
|
|
679 | (2) |
|
Animal Data Relevant to Vitamin D and the Fetus |
|
|
681 | (3) |
|
Human Data Relevant to Vitamin D and the Fetus |
|
|
684 | (6) |
|
Overview of Calcium Metabolism in the Neonate and Infant |
|
|
690 | (2) |
|
Animal Data Relevant to Vitamin D and the Neonate and Infant |
|
|
692 | (1) |
|
Human Data Relevant to Vitamin D and the Neonate and Infant |
|
|
693 | (5) |
|
|
698 | (1) |
|
|
699 | (10) |
|
40 Consequences of Perinatal Vitamin D Deficiency on Later Bone Health |
|
|
|
|
|
|
|
|
|
709 | (1) |
|
Vitamin D Physiology and Epidemiology in Pregnancy |
|
|
709 | (1) |
|
The Lifecourse Determinants of Osteoporosis |
|
|
710 | (7) |
|
Maternal Vitamin D Supplementation During Pregnancy and Offspring Bone Health |
|
|
717 | (4) |
|
Maternal Vitamin D Supplementation During Pregnancy and Offspring Bone Health: The MAVIDOS Trial |
|
|
721 | (3) |
|
|
724 | (1) |
|
|
725 | (1) |
|
|
725 | (6) |
|
41 Adolescence and Acquisition of Peak Bone Mass |
|
|
|
|
|
|
|
731 | (1) |
|
Pubertal Bone Acquisition |
|
|
732 | (2) |
|
|
734 | (2) |
|
Serum 25(OH)D in Children and Adolescents |
|
|
736 | (4) |
|
Vitamin D and Intermediate Endpoints of Vitamin D and Bone Metabolism |
|
|
740 | (3) |
|
Vitamin D and Other Predictors of Calcium Retention |
|
|
743 | (1) |
|
|
743 | (4) |
|
|
747 | (1) |
|
Vitamin D Requirements in Children and Adolescents |
|
|
747 | (1) |
|
|
748 | (1) |
|
|
748 | (7) |
|
42 Pregnancy, Lactation, and Postweaning Recovery |
|
|
|
|
|
755 | (1) |
|
Overview of Mineral Physiology During Pregnancy |
|
|
755 | (4) |
|
Animal Data Relevant to Vitamin D and Pregnancy |
|
|
759 | (2) |
|
Human Data Relevant to Vitamin D and Pregnancy |
|
|
761 | (2) |
|
Overview of Mineral Physiology During Lactation and Postweaning Recovery |
|
|
763 | (7) |
|
Animal Data Relevant to Vitamin D, Lactation, and Postweaning Recovery |
|
|
770 | (1) |
|
Human Data Relevant to Vitamin D, Lactation, and Postweaning Recovery |
|
|
771 | (2) |
|
|
773 | (1) |
|
|
773 | (10) |
|
43 Role in Reproductive Biology and Reproductive Dysfunction in Women |
|
|
|
|
|
|
783 | (1) |
|
Procreative Relevance of Vitamin D---Animal Models |
|
|
784 | (1) |
|
Therapeutic Relevance of Vitamin D---Data From Experimental Animal Models of Human Gynecological Disorders |
|
|
784 | (1) |
|
Vitamin D---Relevance in Human Female Reproductive Physiology |
|
|
785 | (1) |
|
Vitamin D---Relevance in Female Reproductive Disorders |
|
|
785 | (1) |
|
Polycystic Ovary Syndrome |
|
|
785 | (2) |
|
|
787 | (1) |
|
Menstrual Pain (Dysmenorrhea) |
|
|
788 | (1) |
|
|
788 | (1) |
|
Uterine Leiomyomas (Fibroids) |
|
|
789 | (1) |
|
Vitamin D and Female Infertility |
|
|
789 | (3) |
|
|
792 | (1) |
|
|
792 | (5) |
|
44 Vitamin D, Reproductive Biology, and Dysfunction in Men |
|
|
|
|
|
|
|
|
797 | (3) |
|
Vitamin D and Leydig Cell Function |
|
|
800 | (3) |
|
Vitamin D and Sex Steroids |
|
|
803 | (2) |
|
Vitamin D and Sertoli Cell Function |
|
|
805 | (1) |
|
Vitamin D and Germ Cell Function |
|
|
806 | (1) |
|
VDR, Activation and Inactivation of Vitamin D in Human Sperm |
|
|
807 | (1) |
|
Vitamin D and Sperm Function |
|
|
808 | (3) |
|
Vitamin D, Epididymis, Prostate, and Seminal Vesicle |
|
|
811 | (1) |
|
Vitamin D and Reproductive Hormones |
|
|
812 | (1) |
|
Vitamin D, Semen Quality, and Fertility: Functional Models |
|
|
813 | (3) |
|
Vitamin D, Semen Quality, and Fertility: Human Studies |
|
|
816 | (2) |
|
Testicular Germ Cell Tumors |
|
|
818 | (1) |
|
Concluding Remarks and Future Perspectives |
|
|
819 | (1) |
|
|
820 | (5) |
|
45 Vitamin D and the Renin-Angiotensin System |
|
|
|
|
|
825 | (1) |
|
The Renin-Angiotensin System |
|
|
826 | (3) |
|
Vitamin D Regulation of the Renin-Angiotensin System |
|
|
829 | (4) |
|
Vitamin D and the Renin-Angiotensin System in Disease |
|
|
833 | (7) |
|
|
840 | (1) |
|
|
840 | (9) |
|
46 Parathyroid Hormone, Parathyroid Hormone--Related Protein, and Calcitonin |
|
|
|
|
|
849 | (7) |
|
Parathyroid Hormone--Related Protein |
|
|
856 | (5) |
|
|
861 | (3) |
|
|
864 | (7) |
|
47 FGF23 Counter-Regulatory Hormone for Vitamin D Actions on Mineral Metabolism, Hemodynamics, and Innate Immunity |
|
|
|
|
|
871 | (1) |
|
Parathyroid Hormone--Vitamin D Axis: Key Regulator of Calcium Homeostasis |
|
|
872 | (1) |
|
Fibroblast Growth Factor-23/α-Klotho |
|
|
872 | (1) |
|
Fibroblast Growth Factor-23 Endocrine Networks |
|
|
873 | (3) |
|
Noncanonical α-Klotho and Fibroblast Growth Factor-23 Signaling |
|
|
876 | (3) |
|
|
879 | (1) |
|
|
879 | (8) |
|
VI DIAGNOSIS AND MANAGEMENT |
|
|
|
48 Approach to the Patient With Metabolic Bone Disease |
|
|
|
|
|
887 | (1) |
|
|
888 | (9) |
|
Biochemical Investigation |
|
|
897 | (1) |
|
Histopathological Assessment |
|
|
898 | (2) |
|
|
900 | (1) |
|
|
901 | (1) |
|
|
902 | (1) |
|
|
902 | (1) |
|
49 Detection of 1,25-Dihydroxyvitamin D in Human Serum Using Receptor Assisted Chemiluminescent Hormone Assay Technology |
|
|
|
|
|
|
903 | (1) |
|
|
904 | (1) |
|
Identification of the DNA Consensus Sequence of the Immunoglobulin G VH and VL Gene, Expressed by Hybridoma Clone 11B4 |
|
|
905 | (1) |
|
Preparation of the Assay Reagents |
|
|
905 | (1) |
|
Assay Format and Performance |
|
|
905 | (1) |
|
|
906 | (1) |
|
|
907 | (2) |
|
50 Mass Spectrometry Assays of Vitamin D Metabolites |
|
|
|
|
|
|
|
909 | (1) |
|
Approaches and Utility of Vitamin D Metabolite Measurements in the Clinical Laboratory Setting |
|
|
910 | (2) |
|
Overview of Methodology for Analysis of Circulating Vitamin D Metabolites by LC-MS/MS |
|
|
912 | (5) |
|
Application of LC-MS/MS to the Study of Vitamin D Metabolism in Animal Models |
|
|
917 | (3) |
|
|
920 | (1) |
|
|
920 | (5) |
|
51 Free Vitamin D: Concepts, Assays, Outcomes, and Prospects |
|
|
|
|
|
|
925 | (1) |
|
|
926 | (1) |
|
Transportation and Internalization: Free Hormone Hypothesis and Bioavailable Ligand |
|
|
926 | (2) |
|
Vitamin D-Binding Protein Genotype |
|
|
928 | (1) |
|
Free Vitamin D: Mathematical Estimation |
|
|
928 | (1) |
|
Free Vitamin D: Direct Physical Measurement |
|
|
929 | (1) |
|
Potential Utility of Free 25(OH)D for Clinical- and Population-Based Detection of Vitamin D Deficiency |
|
|
930 | (3) |
|
Conclusions and Knowledge Gaps |
|
|
933 | (1) |
|
|
933 | (6) |
|
52 25-Hydroxyvitamin D Assays: Standardization Guidelines, Problems, and Interpretation |
|
|
|
|
|
|
|
939 | (1) |
|
Vitamin D Standardization Program Objectives |
|
|
940 | (1) |
|
Standardization and Traceability |
|
|
941 | (1) |
|
Vitamin D Standardization Program Standardization Protocols |
|
|
942 | (8) |
|
Performance Testing/Quality Assessment of Assays for Vitamin D Metabolites |
|
|
950 | (5) |
|
Vitamin D Standardization Program Efforts Going Into the Future |
|
|
955 | (1) |
|
|
955 | (1) |
|
|
956 | (4) |
|
|
|
|
|
|
|
960 | (1) |
|
|
960 | (1) |
|
|
961 | (2) |
|
Assessment of Mineralization |
|
|
963 | (1) |
|
Histological Diagnosis of Osteomalacia |
|
|
964 | (2) |
|
Assessment of Bone Turnover |
|
|
966 | (1) |
|
Assessment of Remodeling Balance |
|
|
967 | (2) |
|
Assessment of Bone Structure |
|
|
969 | (1) |
|
Influence of Vitamin D Status on Bone Histomorphometry |
|
|
969 | (1) |
|
|
970 | (1) |
|
|
971 | (4) |
|
54 Radiology of Rickets and Osteomalacia |
|
|
|
|
Introduction and Historical Aspects |
|
|
975 | (1) |
|
|
976 | (5) |
|
|
981 | (6) |
|
Renal Tubular Defects and Hypophosphatemia |
|
|
987 | (6) |
|
|
993 | (4) |
|
|
997 | (4) |
|
|
1001 | (1) |
|
|
1001 | (6) |
|
55 High-Resolution Imaging Techniques for Bone Quality Assessment |
|
|
|
|
|
|
|
1007 | (1) |
|
X-ray Computed Tomography |
|
|
1008 | (13) |
|
Magnetic Resonance Imaging |
|
|
1021 | (10) |
|
|
1031 | (12) |
|
56 The Role of Vitamin D in Orthopedic Surgery |
|
|
|
|
|
|
|
|
|
|
1043 | (1) |
|
Impact on Orthopedic Trauma |
|
|
1044 | (4) |
|
Impact on Pediatric Orthopedics |
|
|
1048 | (2) |
|
Impact on Total Joint Arthroplasty |
|
|
1050 | (4) |
|
|
1054 | (9) |
|
Introduction to Chapters 57A and 57B References |
|
|
1063 | (2) |
|
57A The IOM-Endocrine Society Controversy on Recommended Vitamin D Targets: In Support of the IOM Position |
|
|
|
|
|
|
1065 | (2) |
|
Vitamin D Status and Bone Health in Adults and the Elderly |
|
|
1067 | (5) |
|
Vitamin D and Extraskeletal Health |
|
|
1072 | (7) |
|
Lessons From Recently Updated Guidelines on Vitamin D Supplementation |
|
|
1079 | (1) |
|
Vitamin D and Human Health: What is the Optimal Vitamin D Status |
|
|
1079 | (2) |
|
Summary of Recommendations |
|
|
1081 | (1) |
|
|
1082 | (1) |
|
|
1082 | (10) |
|
57B The IOM---Endocrine Society Controversy on Recommended Vitamin D Targets: In Support of the Endocrine Society Position |
|
|
|
|
|
Section I Defining the Disagreement Between IOM and Endocrine Society |
|
|
1092 | (2) |
|
Section II Scientific Basis for Why IOM Versus Endocrine Society Values Differ in Terms of Bone Health |
|
|
1094 | (4) |
|
Section III Toxicity and Perceptions of Risk of Higher Vitamin D Intakes: Higher-Dose Clinical Trials and Epidemiology U-Shaped Risk Findings |
|
|
1098 | (3) |
|
Section IV Extraskeletal Effects of Vitamin D |
|
|
1101 | (1) |
|
Section V Extraskeletal Effects: Cross-Sectional Observations Versus the Findings of Double-Blind, Randomized Clinical Trials |
|
|
1101 | (2) |
|
Section VI Emerging Benefits of Higher Vitamin D: Life Expectancy |
|
|
1103 | (1) |
|
Section VII New Evidence That Vitamin D Lowers Risk of Preterm Birth |
|
|
1103 | (1) |
|
|
1104 | (1) |
References |
|
1105 | (4) |
Index for Volume 1 |
|
1109 | |